# S2B Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/s2b-genotoxicity-a-standard-battery-for-genotoxicity-testing-of-pharmaceuticals/39dc5532-49cc-4723-ab60-cea50fce93fd

> FDA guidance document: S2B Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. Issue date: November 21, 1997. Get complete insights and analysis.

---

## Details

- Title: S2B Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1997-11-21
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1997-D-0199">FDA-1997-D-0199</a>

## Related Documents

- [S1B Testing for Carcinogenicity of Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s1b-testing-for-carcinogenicity-of-pharmaceuticals/8cc92fb9-6b17-465b-8cf3-ba1e865720dd)
- [Q2B Validation of Analytical Procedures: Methodology](https://www.globalkeysolutions.net/guidances/guidance-document/q2b-validation-of-analytical-procedures-methodology/582c54c8-1b4b-41ac-9986-b492b25f4794)
- [S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s6-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/b4092e3c-509e-4d7e-9f1c-4d7274985cc7)